Supreme Court Won't Hear Cubicin Patent Appeal
The U.S. Supreme Court on Tuesday declined to review an infringement case over the antibiotic Cubicin in which Cubist Pharmaceuticals Inc. alleged that lower courts erred in nixing the asserted claims...To view the full article, register now.
Already a subscriber? Click here to view full article